APOTEX CORP. for APOTEX CORP.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, the Patent Reform Act of 2009 concerning inequitable conduct
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Medicare/Medicaid MMM
HR 3200, Subtitle-E, Financing, Section 1741, Payment to Pharmacists Senate Finance and HELP Committee amendments concerning patent settlements between generic and brand drug companies
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Pharmacy PHA
S. 369, the Preserve Access to Affordable Pharmaceuticals Act HR 1706, the Protecting Consumer Access to Generic Drugs Act S. 1315, the Drug Price Competition Act of 2009 HR 3200, Subtitle C - Food & Drug Administration, Section 2563, Protecting Consumer Access to Generic Drugs HR 3200, Subtitle C, Food & Drug Administration, Part 2, Biosimilars Section 2565, Licensure Pathway for Biosimilar Biological Products HR 1427, the Promoting Innovation and Access to Life Savings Medicine Act HR 1548, Pathway for Biosimilars Act
Foreign entity interest: ApoSherm Inc., the parent company of Apotex Corp., has direct or indirect ownership interests in companies that develop, manufacture, and/or sell generic drugs, and therefore has an interest in the issues identified in this report.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN GIULI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.